Patent Number: 6,967,216

Title: Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor

Abstract: Compounds of formula (I): ##STR1## wherein: X is a group of formula (A) or (B): ##STR2## and R.sup.1, R.sup.2, R.sup.3, R.sup.4, n, x, y and z are as defined within are described. Processes for their preparation and their use in the treatment of disorders mediated by the neuropeptide Y5 receptor in a warm-blooded animal, such as a human being are also described.

Inventors: Block; Michael Howard (Macclesfield, GB), Donald; Craig Samuel (Macclesfield, GB), Brittain; David Robert (Macclesfield, GB), Foote; Kevin Michael (Macclesfield, GB)

Assignee: AstraZeneca AB

International Classification: C07D 409/00 (20060101); C07D 409/12 (20060101); C07D 413/12 (20060101); C07D 413/00 (20060101); C07D 333/00 (20060101); C07D 409/14 (20060101); C07D 333/76 (20060101); C07D 495/04 (20060101); C07D 495/00 (20060101); A61K 031/38 (); A61K 031/44 (); A61K 031/40 (); C07D 333/74 (); C07D 211/70 ()

Expiration Date: 1/22/02018